These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 27067332

  • 1. Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
    Cunha-Júnior EF, Martins TM, Canto-Cavalheiro MM, Marques PR, Portari EA, Coelho MG, Netto CD, Costa PR, Sabino KC, Torres-Santos EC.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3794-801. PubMed ID: 27067332
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF, Pacienza-Lima W, Ribeiro GA, Netto CD, do Canto-Cavalheiro MM, da Silva AJ, Costa PR, Rossi-Bergmann B, Torres-Santos EC.
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC, de Paula RC, Alves CL, Faria KF, Oliveira MM, Mendes GG, Dias EMFA, Ribeiro RR, Oliveira AB, Silva SMD.
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [Abstract] [Full Text] [Related]

  • 4. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
    Costa L, Pinheiro RO, Dutra PM, Santos RF, Cunha-Júnior EF, Torres-Santos EC, da Silva AJ, Costa PR, Da-Silva SA.
    PLoS One; 2014 Apr; 9(10):e109672. PubMed ID: 25340550
    [Abstract] [Full Text] [Related]

  • 5. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.
    da Costa-Silva TA, Galisteo AJ, Lindoso JA, Barbosa LR, Tempone AG.
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167544
    [Abstract] [Full Text] [Related]

  • 6. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M, dos Reis Lage LM, Lage DP, Mesquita JT, Salles BC, Lavorato SN, Menezes-Souza D, Roatt BM, Alves RJ, Tavares CA, Tempone AG, Coelho EA.
    Vet Parasitol; 2016 Feb 15; 217():81-8. PubMed ID: 26827866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ, Colombo FA, Pereira-Chioccola VL, Tempone AG.
    Exp Parasitol; 2012 Mar 15; 130(3):195-9. PubMed ID: 22281156
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis.
    Ribeiro GA, Cunha-Júnior EF, Pinheiro RO, da-Silva SA, Canto-Cavalheiro MM, da Silva AJ, Costa PR, Netto CD, Melo RC, Almeida-Amaral EE, Torres-Santos EC.
    J Antimicrob Chemother; 2013 Apr 15; 68(4):789-99. PubMed ID: 23288404
    [Abstract] [Full Text] [Related]

  • 11. Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections.
    Carvalheiro M, Esteves MA, Santos-Mateus D, Lopes RM, Rodrigues MA, Eleutério CV, Scoulica E, Santos-Gomes G, Cruz ME.
    Eur J Pharm Biopharm; 2015 Jun 15; 93():346-52. PubMed ID: 25936854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis.
    Valadares DG, Duarte MC, Ramírez L, Chávez-Fumagalli MA, Martins VT, Costa LE, Lage PS, Ribeiro TG, Castilho RO, Fernandes AP, Régis WC, Soto M, Tavares CA, Coelho EA.
    Exp Parasitol; 2012 Oct 15; 132(2):228-36. PubMed ID: 22824583
    [Abstract] [Full Text] [Related]

  • 14. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
    Gupta S, Yardley V, Vishwakarma P, Shivahare R, Sharma B, Launay D, Martin D, Puri SK.
    J Antimicrob Chemother; 2015 Feb 15; 70(2):518-27. PubMed ID: 25389223
    [Abstract] [Full Text] [Related]

  • 15. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis.
    Mendonça DVC, Martins VT, Lage DP, Dias DS, Ribeiro PAF, Carvalho AMRS, Dias ALT, Miyazaki CK, Menezes-Souza D, Roatt BM, Tavares CAP, Barichello JM, Duarte MC, Coelho EAF.
    Exp Parasitol; 2018 Mar 15; 186():24-35. PubMed ID: 29448040
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.
    Bilbao-Ramos P, Serrano DR, Ruiz Saldaña HK, Torrado JJ, Bolás-Fernández F, Dea-Ayuela MA.
    Molecules; 2020 Mar 19; 25(6):. PubMed ID: 32204358
    [Abstract] [Full Text] [Related]

  • 17. Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis.
    Smith L, Serrano DR, Mauger M, Bolás-Fernández F, Dea-Ayuela MA, Lalatsa A.
    Mol Pharm; 2018 Jul 02; 15(7):2570-2583. PubMed ID: 29762040
    [Abstract] [Full Text] [Related]

  • 18. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
    Martino T, Kudrolli TA, Kumar B, Salviano I, Mencalha A, Coelho MGP, Justo G, Costa PRR, Sabino KCC, Lupold SE.
    Prostate; 2018 Feb 02; 78(2):140-151. PubMed ID: 29105806
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbiéri CL, Uliana SR.
    J Antimicrob Chemother; 2009 Feb 02; 63(2):365-8. PubMed ID: 19095684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.